Decline of a "Gold-Standard" Treatment in Cervical Cancer


Journal of Clinical Pathways spoke with Timothy Showalter, MD, radiation oncologist, University of Virginia Cancer Center, about the decline of brachytherapy use in cervical cancer and the importance of incentivizing quality care in payment policies.

To read the podcast transcript, click here.

Dr Showalter recently co-authored a study, titled "Evaluation of Delivery Costs for External Beam Radiation Therapy and Brachytherapy for Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing," which is referenced in this podcast.